The sulfonylureas and glinides targeting the Kir6.2-Sur1 subunits showed an elevated case report number for pancreatic carcinoma and bladder cancers, but a low number of reports for common cancers. This evidence concerns the gene KCNJ11 and urinary bladder cancer.